Abiopharma

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Iovance Biotherapeutics’ (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% – Hagens Berman

Press Release: AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

Revenge of the Savage Planet: Sequel Goes Bigger, Funnier, and Wilder

Dune: Awakening Beta Now Live – Full Launch Set for June

Everything We Know About AMD’s Upcoming RX 9060 XT – Price, Specs, Dates

ResMed Inc. Daily Stock Update

No Season 2 For ‘Suits LA’ – Show Canceled By NBC After Low Ratings

The Old Guard 2: Netflix Sets Official Release Date with New Trailer